Chronic myelogenous leukemia (CML) is a hematologic cancer that occurs primarily in adults. Although CML can occur at any age, the median age at diagnosis is 64 years, and the incidence increases with age.
Generic Imatinib: Can It Provide Significant Cost Relief for Patients?
Joseph Tkacz, MS, Michael P. Ingham, MSc, Brenna L. Brady, PhD, Roxanne Meyer, PharmD, Charles Ruetsch, PhD
For many years, diseasemodifying antirheumatic drugs (DMARDs) have been the mainstay of RA treatment, reducing inflammation and preventing further joint deterioration and disease progression. In the past 15 years, biologic DMARDs have become available and have proved effective for reducing inflammation and managing the disease.
You Cannot Manage What You Cannot Measure
Evaluating the Expected Costs and Budget Impact of Interventional Therapies for the Treatment of Chronic Venous Disease
Rashad Carlton, PharmD, MSPH, Rajiv Mallick, PhD, Chelsey Campbell, PharmD, MBA, Aditya Raju, MS, BPharm, Thomas O'Donnell, MD, Michael Eaddy, PharmD, PhD, Michael Eaddy, PharmD, PhD, Michael F. Murphy, MD, PhD
Although varicose veins are considered by some policymakers to primarily be an aesthetic concern, varicosities and their resulting sequelae are primary contributors to the morbidity associated with chronic venous diseases.
A Teachable Moment in Health Benefits Design
In forecasting the future of cardiovascular disease (CVD), the American Heart Association calls for preventive strategies, with particular attention to obesity.1 The facts related to the current obesity epidemic are familiar, stark, and bode bad news not only for the physical health of the US population but also for its economic health. Obesity is a common denominator in and a risk factor for many chronic conditions, including diabetes, coronary artery disease (CAD), stroke, and hypertension.2,3
Employers’ Obesity Initiatives in the Workplace: A Wakeup Call for Health Plans
The Economic Impact of Delaying 5-Alpha Reductase Inhibitor Therapy in Men Receiving Treatment for Symptomatic Benign Prostatic Hyperplasia
Michael Naslund, MD, MBA, Michael Eaddy, PharmD, PhD, Susan L. Hogue, PharmD, MPH, Eric J. Kruep, PharmD, MS, Manan B. Shah, PharmD, PhD
Benign prostatic hyperplasia (BPH), also known as enlarged prostate, is a significant health problem among aging men.1 It affects approximately 50% of American men aged 51 to 60 years, 70% of men aged 61 to 70 years, and 90% of men aged 81 to 90 years.2 The burden of BPH on the US healthcare system is expected to grow even further as the population of men aged ≥65 years increases from 17 million in 2010 to approximately 30 million by 2030.3
Benefit Management Considerations for BPH Medications: Single Agent or Combination Therapy?
Andrea Henry, PharmD, MBA, Goldina Ikezuagu Erowele, PharmD, Uche Anadu Ndefo, PharmD, BCPS, Jackie Milton-Brown, PharmD, Enock Anassi, PharmD, MD, Wendy Green, PharmD, MPA, Adriana Alvidrez, PharmD, BCPS, Alphonsus U. Okpara, PharmD
The Harris County Hospital District (HCHD) is an integrated public healthcare system for Harris County, TX, the nation’s third most populous county.1 More than 27% of Harris County residents are uninsured, and Texas state law requires counties to serve the indigent; therefore, most of these uninsured patients receive care at HCHD.2 HCHD is comprised of 3 hospitals, 13 community health centers, 13 satellite homeless shelter clinics, 8 school-based clinics, 4 mobile health clinics, and a free-standing dental center.
A Collaborative Approach to Drug Selection, Driven by Clinical Outcomes Excellence
Recent Trends in the Dispensing of 90-Day-Supply Prescriptions at Retail Pharmacies: Implications for Improved Convenience and Access
Nearly 96% of all employers allow employees and covered beneficiaries to fill medication prescriptions from either retail or mail-service pharmacy. 1 In 2009, mail-service pharmacies dispensed approximately 238 million prescriptions, representing 6.6% of the 3.6 billion prescriptions dispensed that year.2 Mailservice pharmacies have enjoyed high levels of consumer satisfaction.3 Mail-service pharmacies offer consumers the convenience of home delivery, online ordering and renewal processes, and prescriptions filled with a 90-day supply of medication.
When More Is Almost Always Better
Comparing Treatment Persistence, Healthcare Resource Utilization, and Costs in Adult Patients with Major Depressive Disorder Treated with Escitalopram or Citalopram
Eric Q. Wu, PhD, Paul E. Greenberg, MA, Rym Ben-Hamadi, MSc, Andrew P. Yu, PhD, Elaine H. Yang, PhD, M. Haim Erder, PhD
Page 6 of 7
Results 51 - 60 of 64
Results 51 - 60 of 64